title: Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors.
authors.forename: Marius J
authors.initials: MJ
authors.lastname: Coetzee
authors.forename: Vernon J
authors.initials: VJ
authors.lastname: Louw
authors.forename: Kevin
authors.initials: K
authors.lastname: Gartrell
authors.forename: Chris D
authors.initials: CD
authors.lastname: Viljoen
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D018553:Cucumis sativus / Q000009:adverse effects*; D005500:Follow-Up Studies; D005503:Food Additives / Q000009:adverse effects*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D017365:Spices / Q000009:adverse effects*; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D005503:Food Additives; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate